Skip to content

Homoeopathy treatment in shoulder pain

A double blind randomized placebo controlled clinical trial evaluating the efficacy of individualized Homoeopathy in treatment of adhesive capsulitis of shoulder or frozen shoulder. - ACS

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061824
Enrollment
144
Registered
2024-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M750- Adhesive capsulitis of shoulder

Interventions

Intervention1: HOMOEOPATHIC MEDICINES: Individualized Homoeopathic medicine in centesimal potencies manufactured by a licensed homoeopathic pharmaceutical company approved by the Council will be given
dosage and repetition depending upon the individual requirement of the cases. The change of medicine and repetition shall be as per homoeopathic principles.Standard Physiotherapy will be applied by Ph

Sponsors

under Central Council for Research in Homoeopathy (CCRH)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 40 to 65 years 2. All genders 3. Patient with the complaint of pain at the shoulder joint due to Adhesive capsulitis confirmed by Clinical examination, passive ROM (SAB, SER and SIR) measured by Goniometer 4. Goniometer, Digital X-ray, and MRI of the Shoulder Joint to exclude the other causes of pain in the shoulder joint. 5. Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of Adhesive capsulitis, provided the medications are stopped completely at least 2 weeks prior to study entry. 6. Patients suffering from acute diseases like acute upper respiratory tract infection, acute gastro-enteritis, acute toothache, and acute sinusitis may be enrolled after a washout period of 1week following recovery 7. Patients providing voluntary written informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe degeneration of the shoulder joint with marked joint stiffness, evidenced by imaging or other evidence and requiring surgical intervention. 2. Non-ambulant patients 3. Self-reported joint disorders other than Adhesive capsulitis(e.g., inflammatory joint disease, specific arthropathy, severe axis deviations or instabilities, joint or skin infections, joint prostheses of the upper limbs) 4. Intra-articular injections within 2 weeks before study entry. 5. Transplanted shoulder joint. 6. Recent significant surgery in shoulder within last 6 months 7. Patients who are too sick for consultation 8. Unwilling to take part and not giving consent to join the study 9. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life. 10. Pregnancy and lactation 11. Self-reported immune-compromised state, and 12. Undergoing homeopathic treatment for any chronic disease within the last month.

Design outcomes

Primary

MeasureTime frame
The shoulder pain with stiffness and difficulty in physical function and daily living activities will be assessed among the Adhesive capsulitis patients by Shoulder Pain and Disability Index (SPADI) scaleTimepoint: baseline and every month for 6 months

Secondary

MeasureTime frame
The general wellbeing and Quality of life (QoL) will be assessed among ASC patients using ORIDL scoreTimepoint: monthly interval for 6 months

Countries

India

Contacts

Public ContactDr Suraia Parveen

Dr Anjali Chatterji Regional Research Institute For Homoeopathy, Kolkata.

drsuraiya2009@gmail.com7001510319

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026